Korsana Biosciences KRSA Estimates

NASDAQ KRSA
$34.00 +3.17 (+10.28%)
At close: Sep 29, 2026 · 4:00 PM EDT
Analyst Estimates

Korsana Biosciences, Inc. Revenue Estimates

Periods 27
Next Period Q3 22
Consensus 161,913.78

Analysts expect Korsana Biosciences, Inc. to report revenue of 161,913.78 for Q3 22, against a range of 148,464.09 to 175,363.47. The most recent reported quarter, Q2 26, came in at 0.00.

Metric Q2 22Q3 22Q4 22Q1 23Q2 23Q3 23Q4 23Q4 25Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) 306,000.00-------0.00-
High Estimate 371,911.25175,363.470.000.000.000.000.00103,496.59-0.00
Low Estimate 306,215.67148,464.090.000.000.000.000.0091,756.41-0.00
Consensus Estimate 339,063.46161,913.780.000.000.000.000.0097,626.50-0.00
Analyst Estimates

Korsana Biosciences, Inc. Earnings Per Share (EPS) Estimates

Periods 26
Next Period Q3 22
Consensus -42.51

Analysts expect Korsana Biosciences, Inc. to report earnings per share of -42.51 for Q3 22, against a range of -46.24 to -38.78. The most recent reported quarter, Q2 26, came in at -3.42.

Metric Q3 22Q4 22Q1 23Q2 23Q3 23Q4 23Q4 25Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) --------3.42-
High Estimate -38.78-37.90-41.99-38.02-38.78-48.54-2.34--0.85
Low Estimate -46.24-46.12-44.95-41.96-44.68-59.12-2.78--0.91
Consensus Estimate -42.51-42.01-43.47-39.99-41.73-53.83-2.56--0.88

Korsana Biosciences, Inc. Estimates API

Pull Wall Street consensus for Korsana Biosciences, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=KRSA&mode=revenue&api_key=YOUR_API_KEY